Profound Medical Corp. announced that Aaron Davidson has been appointed Chief Financial Officer and Senior Vice-President of Corporate Development, effective May 3, 2018. Mr. Davidson has an accomplished history of leadership success within the global healthcare industry.

Most recently, he was Co-Head and Managing Director of H.I.G. BioHealth Partners, where he focused on investment opportunities with emerging life sciences companies. Mr. Davidson began his career with Eli Lilly and Company, where he spent a decade in various operating management roles in the United States and Canada, including financial management, business development, strategic planning, market research and general management. Mr. Davidson continues to serve as Venture Partner at H.I.G. and on the board of directors of HyperBranch Medical Technology, Intact Vascular and On Target Laboratories.

Previously he led investments in, worked with the management teams of, and represented H.I.G. as a board member of several successful companies, including Alder Biopharmaceuticals (public), Forsight Vision5 (acquired), Gemin X Pharmaceuticals (acquired), Novadaq Technologies (public/acquired), and Salmedix (acquired).